Search
Showing Results For "pharmaceuticals"
India receives $5.34 billion FDI in April-May

India receives $5.34 billion FDI in April-May

22 Jul 2016

New Delhi: India received USD 5.34 billion foreign direct investment in the first two months of the current financial year, Parliament was informed today.

Foreign Direct Investment,   Indian FDI,   Foreign Direct Investment Inflow,   FDI Inflow In India,   Defence FDI,   Pharmaceuticals FDI,   Aviation FDI,   Food FDI,   FDI in Retail,   Minister of Finance for State,   Arjun Ram Meghwal,   Latest Business News ,  
Glenmark settles patent litigation over anti-depressant drug

Glenmark settles patent litigation over anti-depressant drug

22 Dec 2015

New Delhi: Glenmark Pharmaceuticals yesterday announced a patent litigation settlement with Forest Laboratories and Royalty Pharma Collection Trust over anti-depressant drug Savella.

Glenmark,   Glenmark and Forest Laboratories,   Glenmark patent litigation,   Savella,   Glenmark Pharmaceuticals,   Latest business news,  
Centre takes first step towards regulating medical devices

Centre takes first step towards regulating medical devices

12 Jun 2015

Mumbai: In the first effort to regulate an industry that covers everything from thermometers to prostheses, the government plans to set up a regulator to oversee country's USD 4 billion medical device industry.

Regulating medical devices,   Medical device,   Draft policy,   Federal Department of Pharmaceuticals,   Pharmaceuticals,   Latest Business News,  
Lupin to acquire US-based Gavis for USD 880 million

Lupin to acquire US-based Gavis for USD 880 million

23 Jul 2015

New Delhi: Drug major Lupin today said it is acquiring US-based Gavis for USD 880 million (over Rs 5,610 crore) to consolidate presence in the world's largest pharmaceuticals market.

Lupin,   Acquisition of Gavis,   Gavis,   Drug company,   Largest pharmaceuticals market,   Latest Business News,  
 Cipla's arm Medi tab sells stake in Jiangsu for USD 18.5 million

Cipla's arm Medi tab sells stake in Jiangsu for USD 18.5 million

10 Dec 2014

New Delhi: Drug major Cipla on Wednesday said its Mauritius subsidiary Meditab Holdings has signed a deal to sell its entire 48.22 percent stake in China-based Jiangsu Cdymax Pharmaceuticals for USD 18.5 million (over Rs 114 crore).

Cipla,   Mauritius subsidiary,   BSE,   Jiangsu Cdymax Pharmaceuticals,  
FTC passes final order in USD 4 billion Sun-Ranbaxy deal

FTC passes final order in USD 4 billion Sun-Ranbaxy deal

21 Mar 2015

Washington: US anti-trust regulator FTC has passed its final order settling charges that Sun Pharma's USD 4 billion deal to acquire Ranbaxy Laboratories could result in unfair business practices.

FTC ,   Sun Ranbaxy deal,   Sun Pharma,   Ranbaxy Laboratories,   Torrent Pharmaceuticals,  
CCI imposes Rs 64 crore fine on GlaxoSmithKline, Sanofi

CCI imposes Rs 64 crore fine on GlaxoSmithKline, Sanofi

06 Jun 2015

New Delhi: Competition Commission of India (CCI) has slapped a penalty of Rs 64 crore on drugmakers GlaxoSmithKline Pharmaceuticals and Sanofi for collusive bidding in supply of a meningitis vaccine to the government for Haj pilgrims.

CCI,   fine on GlaxoSmithKline,   Sanofi,   Competition Commission,   Drugmakers,   Pharmaceuticals,   Meningitis vaccine,   Haj pilgrims,   Latest Business News,  
Chemicals from personal care products contaminate pools

Chemicals from personal care products contaminate pools

07 Jan 2015

Washington: A new study suggests that apart from urine, pharmaceuticals and chemicals from personal care products end up in swimming pools and may impact your health. These chemicals interact with chlorine to produce disinfection byproducts with unknown properties.

pharmaceuticals,   Chemicals,   chlorine,  personal care products,   Swimming pool,  
Indian-origin scientist finds way to develop better drugs

Indian-origin scientist finds way to develop better drugs

26 Aug 2014

New York: An Indian-origin researcher at Michigan Technological University has deciphered how Glycoconjugates-biomolecules that hold sugars in the body like scaffolds for reacting with other molecules, can lead to new and better drugs.

Indian-origin scientist,   drugs,   scaffolds,   drug,   pharmaceuticals,   ,  
 Glenmark gets shareholders' nod to raise up to USD 300 million

Glenmark gets shareholders' nod to raise up to USD 300 million

31 Dec 2014

New Delhi: Glenmark Pharmaceuticals has received shareholders' nod to raise up to USD 300 million (around Rs 1,890 crore) through issue of securities.

Glenmark Pharmaceuticals,   Bombay Stock Exchange,   BSE,   foreign institutional investors,   FIIs,  

1 2  3  4   

Dont Miss